DEF 14A

Company

ADMA BIOLOGICS, INC.

Filed

April 13, 2023

Period of Report

June 6, 2023

Accession Number

0001140361-23-018237

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →